Literature DB >> 12533631

Absence of thermal hyperalgesia in serotonin transporter-deficient mice.

Carola Vogel1, Rainald Mössner, Manfred Gerlach, Thoralf Heinemann, Dennis L Murphy, Peter Riederer, Klaus-Peter Lesch, Claudia Sommer.   

Abstract

Antidepressants in the treatment of neuropathic pain are thought to partially exert their effect by inhibition of serotonin (5-HT) reuptake and thus activation of central antinociceptive pathways. Mice deficient for the 5-HT transporter (5-HTT-/- mice) are regarded as a model of lifelong treatment with a serotonin reuptake inhibitor. Here we investigated 5-HTT-/- mice and compared their pain-related behavior after a unilateral chronic constrictive sciatic nerve injury (CCI) with that of wild-type littermates. Wild-type mice reproducibly developed ipsilateral thermal hyperalgesia and mechanical allodynia after CCI. 5-HTT-/- mice did not develop thermal hyperalgesia, but showed bilateral mechanical allodynia after the nerve injury. 5-HT levels as measured with HPLC increased after CCI in the injured nerve in both genotypes and decreased in the lumbar spinal cord in wild-type mice. 5-HTT-/- mice had significantly lower 5-HT concentrations than wild-type mice in all tissues investigated. Thus, in 5-HTT-/- mice, reduced 5-HT levels in the injured peripheral nerves correlate with diminished behavioral signs of thermal hyperalgesia, a pain-related symptom caused by peripheral sensitization. In contrast, bilateral mechanical allodynia, a centrally mediated phenomenon, was associated with decreased spinal 5-HT concentrations in 5-HTT-/- mice and may possibly be caused by a lack of spinal inhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12533631      PMCID: PMC6741887     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

Review 1.  Does the right side know what the left is doing?

Authors:  M Koltzenburg; P D Wall; S B McMahon
Journal:  Trends Neurosci       Date:  1999-03       Impact factor: 13.837

2.  Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter.

Authors:  A Rioux; V Fabre; K P Lesch; R Moessner; D L Murphy; L Lanfumey; M Hamon; M P Martres
Journal:  Neurosci Lett       Date:  1999-03-05       Impact factor: 3.046

3.  Serotonergic gene transcriptional control regions: targets for antidepressant drug development?

Authors:  Klaus Peter Lesch; Armin Heils
Journal:  Int J Neuropsychopharmacol       Date:  2000-03       Impact factor: 5.176

4.  Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?

Authors:  M J Field; S Bramwell; J Hughes; L Singh
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

5.  Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy.

Authors:  Y X Wang; S S Bowersox; M Pettus; D Gao
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

6.  Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral.

Authors:  H Obata; S Saito; K Ishizaki; F Goto
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

7.  Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects.

Authors:  M J Esser; J Sawynok
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

8.  Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury.

Authors:  B C Hains; K M Chastain; A W Everhart; D J McAdoo; C E Hulsebosch
Journal:  Exp Neurol       Date:  2000-08       Impact factor: 5.330

9.  Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.

Authors:  V Fabre; C Beaufour; A Evrard; A Rioux; N Hanoun; K P Lesch; D L Murphy; L Lanfumey; M Hamon; M P Martres
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

10.  Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat.

Authors:  J Sawynok; M J Esser; A R Reid
Journal:  Pain       Date:  1999-08       Impact factor: 6.961

View more
  35 in total

1.  Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.

Authors:  S Ohnami; A Kato; K Ogawa; S Shinohara; H Ono; M Tanabe
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

Review 3.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

4.  Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells.

Authors:  Jens Benninghoff; Angela Gritti; Matteo Rizzi; Giuseppe Lamorte; Robert J Schloesser; Angelika Schmitt; Stefanie Robel; Just Genius; Rainald Moessner; Peter Riederer; Husseini K Manji; Heinz Grunze; Dan Rujescu; Hans-Juergen Moeller; Klaus-Peter Lesch; Angelo Luigi Vescovi
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

5.  5-HT3 receptor signaling in serotonin transporter-knockout rats: a female sex-specific animal model of visceral hypersensitivity.

Authors:  Nadine El-Ayache; James J Galligan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-25       Impact factor: 4.052

Review 6.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

Review 7.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

8.  Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats.

Authors:  Li-Jen Lee
Journal:  Neurotox Res       Date:  2009-03-04       Impact factor: 3.911

Review 9.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans.

Authors:  Eva Kosek; Karin B Jensen; Tina B Lonsdorf; Martin Schalling; Martin Ingvar
Journal:  Mol Pain       Date:  2009-07-01       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.